Feedback

Tuberculous Pleural Disease

Paula A. Ugalde, Guilherme Dal Agnol, Arthur Vieira
Tuberculous Pleural Disease is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Key Points

  • Pleural tuberculosis occurs 3 to 7 months after primary pulmonary tuberculosis and is usually secondary to the rupture of a subpleural caseous focus.
  • Pleural tuberculosis is self-limited, with 80% of patients achieving complete remission without treatment.
  • If pleural tuberculosis is left untreated, 65% of patients will develop active (pulmonary or extrapulmonary) disease within 5 years.
  • Pleural needle biopsy of pleural tuberculosis for histologic and microbiologic study has 80% to 90% sensitivity.
  • Treatment of pleural tuberculosis consists of 6 months of chemotherapy.
  • Tuberculous empyema results from the rupture of a parenchymal pulmonary tuberculous focus with a large number of organisms spilling into the pleural space.
  • In acute tuberculous empyema, bronchopleural fistula is usually present.
  • Chronic tuberculous empyema may develop if an acute empyema is not recognized or is not properly treated.
  • The treatment goals for tuberculous empyema are to clean the pleural cavity until the space is sterile and to obliterate the residual pleural space.

-- To view the remaining sections of this topic, please or --

Key Points

  • Pleural tuberculosis occurs 3 to 7 months after primary pulmonary tuberculosis and is usually secondary to the rupture of a subpleural caseous focus.
  • Pleural tuberculosis is self-limited, with 80% of patients achieving complete remission without treatment.
  • If pleural tuberculosis is left untreated, 65% of patients will develop active (pulmonary or extrapulmonary) disease within 5 years.
  • Pleural needle biopsy of pleural tuberculosis for histologic and microbiologic study has 80% to 90% sensitivity.
  • Treatment of pleural tuberculosis consists of 6 months of chemotherapy.
  • Tuberculous empyema results from the rupture of a parenchymal pulmonary tuberculous focus with a large number of organisms spilling into the pleural space.
  • In acute tuberculous empyema, bronchopleural fistula is usually present.
  • Chronic tuberculous empyema may develop if an acute empyema is not recognized or is not properly treated.
  • The treatment goals for tuberculous empyema are to clean the pleural cavity until the space is sterile and to obliterate the residual pleural space.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: April 5, 2020